Gregory Madison

Gregory Madison

Corporate Officer/Principal at PROKIDNEY CORP.
59 year
Health Technology
Health Services
Consumer Services

Profile

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Gregory Madison active positions

CompaniesPositionStart
PROKIDNEY CORP. Corporate Officer/Principal 2026-03-24
Director/Board Member -
Director/Board Member 2021-06-17

Former positions of Gregory Madison

CompaniesPositionEnd
SHIELD THERAPEUTICS PLC Chief Executive Officer 2024-07-23
KERYX BIOPHARMACEUTICALS Chief Executive Officer 2018-04-29
Director/Board Member 2014-09-29
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 2014-02-06
Corporate Officer/Principal 2011-12-31
See the detail of Gregory Madison's experience

Training of Gregory Madison

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Gregory Madison